Journal article · 2021
TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy
Advanced Therapeutics, 4(8) · Published 22 July 2021 · DOI 10.1002/adtp.202100086
In brief
“TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy” is a 2021 journal article by Vaishali Malik and 2 co-authors, published in Advanced Therapeutics. OpenAlex counts 11 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 11
- Most cited in
- 2023 (4)
- Field-weighted impact
- 0.79
- References
- 46
- Authors
- 3
Abstract
Tumor‐associated macrophages (TAMs) are among the most abundant immune cells in the solid tumor microenvironment, making them an attractive target for cancer immunotherapy. However, there are two important challenges. First, tumors repolarize the TAMs predominantly to M2 tumor‐aiding phenotype by secreting various immunosuppressive cytokines. Second, CD47 on cancer cells interacts with signal‐regulating protein a (SIRPa)… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Malik, V., Ramesh, A., & Kulkarni, A. A. (2021). TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy. Advanced Therapeutics, 4(8). https://doi.org/10.1002/adtp.202100086
MLA 9
Malik, Vaishali, et al. “TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy.” Advanced Therapeutics, vol. 4, no. 8, 2021. https://doi.org/10.1002/adtp.202100086.
Chicago
Malik, Vaishali, Anujan Ramesh, and Ashish A. Kulkarni. 2021. “TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy.” Advanced Therapeutics 4 (8). https://doi.org/10.1002/adtp.202100086.
Harvard
Malik, V., Ramesh, A. and Kulkarni, A. A. (2021) ‘TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy’, Advanced Therapeutics, 4(8). doi:10.1002/adtp.202100086.
IEEE
V. Malik, A. Ramesh, and A. A. Kulkarni, “TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy,” Advanced Therapeutics, vol. 4, no. 8, 2021, doi: 10.1002/adtp.202100086.
BibTeX
@article{malik2021agonist,
title = {{TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy}},
author = {Malik, Vaishali and Ramesh, Anujan and Kulkarni, Ashish A.},
journal = {Advanced Therapeutics},
year = {2021},
volume = {4},
number = {8},
doi = {10.1002/adtp.202100086},
url = {https://doi.org/10.1002/adtp.202100086}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 3 | |
| 2023 | 4 | |
| 2024 | 2 | |
| 2025 | 1 | |
| 2026 | 1 |
Its field-weighted citation impact is 0.79: it has been cited 0.79 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- tumor-associated macrophages
- TLR7/8 agonist
- R848
- SHP2 inhibitors
- SHP099
- lipid nanoparticles
- M2 macrophage polarization
- M1 macrophage phenotype
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Malik, V., Ramesh, A., & Kulkarni, A. A. (2021). TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy. Advanced Therapeutics, 4(8). https://doi.org/10.1002/adtp.202100086
How many times has this paper been cited?
11 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Vaishali Malik, Anujan Ramesh, Ashish A. Kulkarni.
What is the DOI of this paper?
10.1002/adtp.202100086, permanently at https://doi.org/10.1002/adtp.202100086. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.